
Abstract The case of an elderly woman is reported in whom alendronate, given for osteoporosis, led to severe hypocalcaemia a few days after starting the drug treatment. This was caused by the unmasking of previously unrecognised hypoparathyroidism.
Calcium Channel Agonists, Alendronate, Calcitriol, Hypocalcemia, Hypoparathyroidism, Humans, Female, Osteoporosis, Postmenopausal, Aged, Calcium Carbonate
Calcium Channel Agonists, Alendronate, Calcitriol, Hypocalcemia, Hypoparathyroidism, Humans, Female, Osteoporosis, Postmenopausal, Aged, Calcium Carbonate
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 21 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
